These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 29681898)
1. The Versatile Mutational Resistome of López-Causapé C; Cabot G; Del Barrio-Tofiño E; Oliver A Front Microbiol; 2018; 9():685. PubMed ID: 29681898 [TBL] [Abstract][Full Text] [Related]
2. Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone. López-Causapé C; Sommer LM; Cabot G; Rubio R; Ocampo-Sosa AA; Johansen HK; Figuerola J; Cantón R; Kidd TJ; Molin S; Oliver A Sci Rep; 2017 Jul; 7(1):5555. PubMed ID: 28717172 [TBL] [Abstract][Full Text] [Related]
3. Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing. Cabot G; López-Causapé C; Ocampo-Sosa AA; Sommer LM; Domínguez MÁ; Zamorano L; Juan C; Tubau F; Rodríguez C; Moyà B; Peña C; Martínez-Martínez L; Plesiat P; Oliver A Antimicrob Agents Chemother; 2016 Dec; 60(12):7415-7423. PubMed ID: 27736752 [TBL] [Abstract][Full Text] [Related]
4. Evolution of the Pseudomonas aeruginosa Aminoglycoside Mutational Resistome López-Causapé C; Rubio R; Cabot G; Oliver A Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437613 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of antibiotic resistance in Fernández-Billón M; Llambías-Cabot AE; Jordana-Lluch E; Oliver A; Macià MD Biofilm; 2023 Dec; 5():100129. PubMed ID: 37205903 [No Abstract] [Full Text] [Related]
9. Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates. Cabot G; Zamorano L; Moyà B; Juan C; Navas A; Blázquez J; Oliver A Antimicrob Agents Chemother; 2016 Jan; 60(3):1767-78. PubMed ID: 26729493 [TBL] [Abstract][Full Text] [Related]
10. Comparative Genomics Reveals a Well-Conserved Intrinsic Resistome in the Emerging Multidrug-Resistant Pathogen Cupriavidus gilardii. Ruiz C; McCarley A; Espejo ML; Cooper KK; Harmon DE mSphere; 2019 Oct; 4(5):. PubMed ID: 31578249 [TBL] [Abstract][Full Text] [Related]
11. The increasing threat of Pseudomonas aeruginosa high-risk clones. Oliver A; Mulet X; López-Causapé C; Juan C Drug Resist Updat; 2015; 21-22():41-59. PubMed ID: 26304792 [TBL] [Abstract][Full Text] [Related]
12. Insights into the evolution of the mutational resistome of Pseudomonas aeruginosa in cystic fibrosis. López-Causapé C; Oliver A Future Microbiol; 2017 Dec; 12():1445-1448. PubMed ID: 29068237 [No Abstract] [Full Text] [Related]
13. Global emergence of the widespread Pseudomonas aeruginosa ST235 clone. Treepong P; Kos VN; Guyeux C; Blanc DS; Bertrand X; Valot B; Hocquet D Clin Microbiol Infect; 2018 Mar; 24(3):258-266. PubMed ID: 28648860 [TBL] [Abstract][Full Text] [Related]
14. Penicillin-binding protein 3 is a common adaptive target among Pseudomonas aeruginosa isolates from adult cystic fibrosis patients treated with β-lactams. Clark ST; Sinha U; Zhang Y; Wang PW; Donaldson SL; Coburn B; Waters VJ; Yau YCW; Tullis DE; Guttman DS; Hwang DM Int J Antimicrob Agents; 2019 May; 53(5):620-628. PubMed ID: 30664925 [TBL] [Abstract][Full Text] [Related]
15. SPM-1-producing Pseudomonas aeruginosa ST277 carries a chromosomal pack of acquired resistance genes: An example of high-risk clone associated with 'intrinsic resistome'. Galetti R; Andrade LN; Varani AM; Darini ALC J Glob Antimicrob Resist; 2019 Mar; 16():183-186. PubMed ID: 30586621 [TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa populations in the cystic fibrosis lung lose susceptibility to newly applied β-lactams within 3 days. Tueffers L; Barbosa C; Bobis I; Schubert S; Höppner M; Rühlemann M; Franke A; Rosenstiel P; Friedrichs A; Krenz-Weinreich A; Fickenscher H; Bewig B; Schreiber S; Schulenburg H J Antimicrob Chemother; 2019 Oct; 74(10):2916-2925. PubMed ID: 31355848 [TBL] [Abstract][Full Text] [Related]
17. The intrinsic resistome of Pseudomonas aeruginosa to β-lactams. Alvarez-Ortega C; Wiegand I; Olivares J; Hancock RE; Martínez JL Virulence; 2011; 2(2):144-6. PubMed ID: 21304266 [TBL] [Abstract][Full Text] [Related]
18. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis. Waters V; Ratjen F Cochrane Database Syst Rev; 2017 Jun; 6(6):CD006961. PubMed ID: 28628280 [TBL] [Abstract][Full Text] [Related]
19. Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis. Sherrard LJ; Tai AS; Wee BA; Ramsay KA; Kidd TJ; Ben Zakour NL; Whiley DM; Beatson SA; Bell SC PLoS One; 2017; 12(3):e0172179. PubMed ID: 28273168 [TBL] [Abstract][Full Text] [Related]
20. Occurrence of antipseudomonal beta-lactams and aminoglycosides resistance in Pseudomonas aeruginosa during therapy. Pagani L; Scarabelli M; Cereda PM; Debiaggi M Microbiologica; 1987 Jan; 10(1):103-10. PubMed ID: 3106759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]